$PL

Robinson Kristen sold $930K of PL (indirect holdings)

Robinson Kristen sold 37,107 indirectly-held shares of Planet Labs PBC (PL) at $25.05 ($0.93M total) on 2026-07-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Robinson Kristen
Published Jul 16, 2026, 8:11 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 16, 2026, 8:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$PL
Neutral
high confidence
Mentioned
$PL
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PLNeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale of 37,107 shares at $25.0529/share, totaling $929,637.96, with holdings after the sale of 222,897 shares.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 structure suggests limited fundamental information content.

03

What to watch

The sale is indirect and under a pre-arranged plan; without additional context (e.g., total insider activity trend), the signal is likely weak.

Relevance 4/10Novelty 3/10Timing: Filed on 2026-07-16, transaction dated 2026-07-15.

Background

The article is a SEC Form 4 insider transaction disclosure for Planet Labs PBC, reported by director Robinson Kristen.

Company-level read

Ticker impact

$PLNeutralHigh confidence
Context

Planet Labs PBC director Robinson Kristen sold 37,107 shares in an open-market transaction worth about $929,638 under a 10b5-1 plan.

Expected impact

Likely minimal immediate price impact; any effect would be sentiment-driven and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction, but it is explicitly tied to a pre-arranged 10b5-1 plan, reducing the likelihood of new, time-sensitive negative information.

Market effects

No clear sector read-through from a single director 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can still coincide with periods of weaker outlook or liquidity needs, so some traders may treat it as a mild negative sentiment input.

Key entities

  • Planet Labs PBC

    Company whose director insider transaction is disclosed on Form 4.

  • Robinson Kristen

    Director who executed an open-market sale under a Rule 10b5-1 plan.

Related articles

$PLMed

Scottish Government Selects Planet Labs PBC for AI-Enabled Monitoring to Support Sustainable Agricultural Reform

Planet Labs PBC (NYSE: PL) said the Scottish Government selected it for a one-year, seven-figure award via Computacenter to provide PlanetScope satellite data and analytics for Scotland’s Agricultural Reform Route Map. The program runs through 2026 to support monitoring for biodiversity, food production, and carbon-emissions targets, according to Planet.

$PLMed

Planet Labs Rallies on Renewed Optimism in Space Stocks Following the Rocket Lab-Iridium Partnership

Planet Labs said it extended an NGA contract under the Luno B IDIQ framework, adding a one-year $22M option for Maritime Domain Awareness and a new Global Monitoring Service award for crisis response. It shipped Pelican 11 to Vandenberg for a SpaceX Transporter 17 launch and shared AIRS reentry data with the University of Southampton. Next earnings are Sept. 14; Q2 revenue guidance is $102–$107M and analysts’ average target is $41.